A new study has said that a patient who has fatty liver disease may be prone to an increased risk of heart disease and also the mortality rates that are associated with it. NAFLD or non alcoholic fatty liver disease is becoming increasing common, especially in people who are diagnosed with obesity, type 2 diabetes and arterial hypertension. The research was conducted by scientists at the Pierre and Marie Curie University in Paris. The study was published in the Journal of Hepatology.
Say the researchers, Evidence indicates that the fatty and inflamed liver expresses several pro-inflammatory and procoagulant factors, as well as genes involved in accelerated atherogenesis. This raises the possibility that the link between NAFLD and cardiovascular mortality might not simply be mediated by shared, underlying, common risk factors, but rather that NAFLD independently contributes to increasing this risk. This indicates that NAFLD is a precursor of metabolic syndrome. It follows that the diagnosis of fatty liver is extremely important and therefore a thorough cardiovascular and metabolic work-up and strict monitoring of CVD or metabolic complications are needed in the clinical management of NAFLD. Strict monitoring of cardiovascular disease recommended when managing nonalcoholic fatty liver disease.